Funding and Investments

Nov 04, 2016
By BioPharm International Editors
The company invested more than €250 in production in China.
Nov 01, 2016
By BioPharm International Editors
Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.
Oct 12, 2016
By BioPharm International Editors
The company invested more than CHF 100 million in a new Delaware manufacturing plant.
Oct 03, 2016
By BioPharm International Editors
The company invested in a new cGMP facility located in Berlin, Germany.
Sep 07, 2016
By BioPharm International Editors
The department gave Moderna $8.2 million to accelerate development of an mRNA-based Zika vaccine.
Jun 15, 2016
BioPharm International
By BioPharm International Editors
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
Oct 08, 2015
Through the Glycoscience Program, the National Institute of Health will contribute $10 million to advance the study of carbohydrates and the compounds that interact with them.
Sep 22, 2015
By BioPharm International Editors
Six grants from the NIH will help identify variants in the genome’s regulatory regions that affect disease risk, using new computational approaches.
Jun 18, 2015
By BioPharm International Editors
GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.
Jan 22, 2015
By BioPharm International Editors
Syncona and Kite Pharma announced separate investments into T-cell therapies to fight cancerous tumors.
native1_300x100
lorem ipsum